|
US20030032788A1
(en)
|
1997-07-03 |
2003-02-13 |
Thomas Jefferson University |
Methods of inhibiting alcohol consumption
|
|
BR0008355A
(pt)
*
|
1999-08-30 |
2002-07-16 |
Wisconsin Alumni Res Found |
Produção de ácido 3-hidroxipropionico em organismos recombinantes
|
|
ES2336887T5
(es)
|
2000-03-30 |
2019-03-06 |
Whitehead Inst Biomedical Res |
Mediadores de interferencia por ARN específicos de secuencias de ARN
|
|
CA2429814C
(en)
|
2000-12-01 |
2014-02-18 |
Thomas Tuschl |
Rna interference mediating small rna molecules
|
|
US20050159378A1
(en)
|
2001-05-18 |
2005-07-21 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA)
|
|
US20050019915A1
(en)
|
2001-06-21 |
2005-01-27 |
Bennett C. Frank |
Antisense modulation of superoxide dismutase 1, soluble expression
|
|
WO2003040395A2
(en)
|
2001-11-07 |
2003-05-15 |
Applera Corporation |
Universal nucleotides for nucleic acid analysis
|
|
AU2003295600A1
(en)
*
|
2002-11-14 |
2004-06-15 |
Dharmacon, Inc. |
Functional and hyperfunctional sirna
|
|
US20070265220A1
(en)
|
2004-03-15 |
2007-11-15 |
City Of Hope |
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
|
|
US20050287570A1
(en)
|
2004-05-26 |
2005-12-29 |
Wyeth |
Probe arrays for expression profiling of rat genes
|
|
WO2007030167A1
(en)
|
2005-09-02 |
2007-03-15 |
Nastech Pharmaceutical Company Inc. |
Modification of double-stranded ribonucleic acid molecules
|
|
DK2341943T3
(en)
|
2008-09-22 |
2019-02-25 |
Dicerna Pharmaceuticals Inc |
COMPOSITIONS AND METHODS OF SPECIFIC INHIBITION OF DSRNA REPRINT WITH MODIFICATIONS
|
|
US8691971B2
(en)
|
2008-09-23 |
2014-04-08 |
Scott G. Petersen |
Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating RNA interference
|
|
US20100249214A1
(en)
|
2009-02-11 |
2010-09-30 |
Dicerna Pharmaceuticals |
Multiplex dicer substrate rna interference molecules having joining sequences
|
|
KR101728655B1
(ko)
|
2008-12-18 |
2017-04-19 |
다이서나 파마수이티컬, 인크. |
유전자 발현의 특이적 억제를 위한 연장된 다이서 기질 제제 및 방법
|
|
WO2011005860A2
(en)
|
2009-07-07 |
2011-01-13 |
Alnylam Pharmaceuticals, Inc. |
5' phosphate mimics
|
|
WO2011133871A2
(en)
|
2010-04-22 |
2011-10-27 |
Alnylam Pharmaceuticals, Inc. |
5'-end derivatives
|
|
KR20120005240A
(ko)
|
2010-07-08 |
2012-01-16 |
한양대학교 산학협력단 |
제2알데하이드 탈수소효소의 발현을 억제하는 인공 마이크로 ｒｎａ 및 이의 이용
|
|
JP2014530602A
(ja)
*
|
2011-10-05 |
2014-11-20 |
プロティバ バイオセラピューティクス インコーポレイテッド |
アルデヒドデヒドロゲナーゼをサイレンシングするための組成物および方法
|
|
AU2012328680A1
(en)
|
2011-10-25 |
2014-05-01 |
Ionis Pharmaceuticals, Inc. |
Antisense modulation of GCCR expression
|
|
EP2928877B1
(en)
|
2012-12-06 |
2020-01-22 |
Merck Sharp & Dohme Corp. |
Disulfide masked prodrug compositions and methods
|
|
US10677795B2
(en)
|
2014-05-09 |
2020-06-09 |
Protagen Ag |
Marker sequences for the diagnosis and stratification of systemic sclerosis patients
|
|
CA2950960A1
(en)
|
2014-06-06 |
2015-12-10 |
Solstice Biologics, Ltd. |
Polynucleotide constructs having bioreversible and non-bioreversible groups
|
|
DK3569711T3
(da)
*
|
2014-12-15 |
2021-02-22 |
Dicerna Pharmaceuticals Inc |
Ligandmodificerede dobbeltstrengede nukleinsyrer
|
|
US10689647B2
(en)
*
|
2015-05-08 |
2020-06-23 |
Dicerna Pharmaceuticals, Inc. |
Methods and compositions for the specific inhibition of antithrombin 3 (AT3) by double-stranded RNA
|
|
JP7249080B2
(ja)
|
2016-08-23 |
2023-03-30 |
ディセルナ ファーマシューティカルズ インコーポレイテッド |
可逆的に修飾されたオリゴヌクレオチドを含む組成物及びその使用
|
|
HUE059718T2
(hu)
|
2016-09-02 |
2022-12-28 |
Dicerna Pharmaceuticals Inc |
4'-foszfát analógok és azokat tartalmazó oligonukleotidok
|
|
IL269517B2
(en)
|
2017-04-05 |
2025-01-01 |
Silence Therapeutics Gmbh |
Nucleic acids for inhibiting expression of a target gene in a cell, conjugates thereof, compositions containing them, and medical uses thereof
|
|
DK3607069T3
(da)
|
2017-04-05 |
2022-11-21 |
Silence Therapeutics Gmbh |
Produkter og sammensætninger
|
|
WO2019075419A1
(en)
|
2017-10-13 |
2019-04-18 |
Dicerna Pharmaceuticals, Inc. |
METHODS AND COMPOSITIONS FOR INHIBITING LDHA EXPRESSION
|
|
HRP20230127T1
(hr)
|
2017-11-13 |
2023-03-31 |
Silence Therapeutics Gmbh |
Nukleinske kiseline za inhibiranje ekspresije lpa u stanici
|
|
EP3735461A1
(en)
|
2017-11-13 |
2020-11-11 |
Silence Therapeutics GmbH |
Nucleic acids for inhibiting expression of aldh2 in a cell
|
|
KR20200109311A
(ko)
|
2018-01-16 |
2020-09-22 |
다이서나 파마수이티컬, 인크. |
Aldh2 발현을 억제하기 위한 조성물 및 방법
|
|
BR112021019793A2
(pt)
|
2019-04-04 |
2021-12-07 |
Dicerna Pharmaceuticals Inc |
Composições e métodos para inibir expressão de gene no sistema nervoso central
|
|
EP4244356A1
(en)
|
2020-11-13 |
2023-09-20 |
Dicerna Pharmaceuticals, Inc. |
Chemical modifications for inhibiting expression of aldh2
|